Steering the course of CAR T cell therapy with lipid nanoparticles
Abstract Lipid nanoparticles (LNPs) have proven themselves as transformative actors in chimeric antigen receptor (CAR) T cell therapy, surpassing traditional methods and addressing challenges like immunogenicity, reduced toxicity, and improved safety. Promising preclinical results signal a shift tow...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2024-06-01
|
| coleção: | Journal of Nanobiotechnology |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s12951-024-02630-1 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|